- Stocks
- Diversified
- 3B Blackbio Dx
3B Blackbio Dx share price
NSE: 3BBLACKBIODiversified
3B Blackbio Dx at a glance
3B Blackbio Dx (NSE: 3BBLACKBIO) closed at ₹1,316.60 on 22 Oct 2026, down 0.47% on the day. With a market capitalisation of ₹1,130 Cr, it ranks 1394th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Diversified sector.
Its return on equity was 18.1% in FY26. Its 52-week range is ₹1,085.00 (2 Jun 2026) to ₹1,740.00 (30 Sep 2026); the last close is 24.3% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹35 Cr (+57.5% year on year) and net profit ₹10 Cr (+21.9%), on a consolidated basis. Promoters held 40.95% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹1,130 CrRank 1394 on NSE
- Price to book
- 2.97×FY26
- EPS (TTM)
- ₹69.94to Q4 FY26
- ROE
- 18.1%FY26
- ROCE
- 22.6%FY26
- Debt to equity
- 0.01FY26
- Net profit margin
- 42.2%FY26
- Book value / share
- ₹378.58FY26
- 52-week high
- ₹1,740.0030 Sep 2026
- 52-week low
- ₹1,085.002 Jun 2026
- RSI (14-day)
- 37.4
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.47% | −9.3% | −6.9% | +1.9% | — |
3B Blackbio Dx quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹19 Cr | ₹29 Cr | ₹25 Cr | ₹23 Cr | ₹22 Cr | ₹34 Cr | ₹50 Cr | ₹35 Cr |
| Revenue YoY | +36.1% | +52.0% | +43.7% | −2.2% | +14.4% | +16.3% | +98.3% | +57.5% |
| Net profit | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹8 Cr | ₹13 Cr | ₹15 Cr | ₹22 Cr | ₹10 Cr |
| Net profit YoY | +56.7% | +95.8% | +58.5% | −8.5% | +11.9% | +1.2% | +66.2% | +21.9% |
| Net margin | 58.2% | 51.0% | 53.2% | 35.7% | 56.9% | 44.4% | 44.6% | 27.7% |
| EPS | ₹13.19 | ₹17.35 | ₹15.75 | ₹9.38 | ₹14.76 | ₹17.55 | ₹26.19 | ₹11.44 |
3B Blackbio Dx financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹227 Cr | ₹81 Cr | ₹62 Cr | ₹74 Cr | ₹96 Cr | — |
| Operating profit | ₹152 Cr | ₹43 Cr | ₹35 Cr | ₹44 Cr | ₹64 Cr | — |
| Net profit | ₹114 Cr | ₹32 Cr | ₹26 Cr | ₹32 Cr | ₹48 Cr | — |
| EPS (₹) | ₹152.00 | ₹43.00 | ₹35.00 | ₹37.00 | ₹56.00 | — |
| Cash from operations | ₹98 Cr | ₹37 Cr | ₹23 Cr | ₹27 Cr | ₹43 Cr | — |
| Total debt | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹3 Cr |
| Shareholders' equity | ₹132 Cr | ₹153 Cr | ₹171 Cr | ₹223 Cr | ₹268 Cr | ₹324 Cr |
3B Blackbio Dx shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 41.28% | 41.28% | 41.28% | 41.28% | 40.94% | 40.95% |
| Foreign institutions | 2.49% | 2.70% | 2.64% | 2.57% | 2.57% | 2.50% |
| Domestic institutions | 1.60% | 1.76% | 1.82% | 1.88% | 1.98% | 2.15% |
| Non-institutions | 54.63% | 54.26% | 54.26% | 54.28% | 54.51% | 54.40% |
3B Blackbio Dx vs peers
The listed Diversified companies nearest to 3B Blackbio Dx by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| BOMDYEINGBOMDYEING | ₹92.13 | −0.44% | −46.0% | ₹1,903 Cr | — | — |
| SIKASika Interplant Systems | ₹894.90 | −1.17% | — | ₹1,897 Cr | — | — |
| GRANDOAKGrand Oak Canyons Distillery | ₹35.48 | +7.84% | — | ₹1,841 Cr | — | — |
| KOTICKothari Industrial Corporation | ₹133.76 | −1.65% | — | ₹1,445 Cr | — | — |
| FEDDERSHOLFedders Holding | ₹57.00 | +5.26% | — | ₹1,148 Cr | — | — |
| 3BBLACKBIO3B Blackbio Dx | ₹1,316.60 | −0.47% | — | ₹1,130 Cr | — | — |
| SAFEENTPSafe Enterprise | ₹227.20 | −1.22% | +23.5% | ₹1,059 Cr | — | — |
Ask anything about 3B Blackbio Dx
Pivot answers on the live chart with evidence you can check, and tests strategies against 3BBLACKBIO's own history. Try: “Why has 3BBLACKBIO moved over the last three months?” · “Backtest a 50-day moving-average crossover on 3BBLACKBIO over five years” · “Compare 3BBLACKBIO with BOMDYEING on margins and valuation”
Frequently asked questions about 3B Blackbio Dx
What is the share price of 3B Blackbio Dx today?
3B Blackbio Dx (NSE: 3BBLACKBIO) last closed at ₹1,316.60 on 22 Oct 2026. Its 52-week high is ₹1,740.00 and its 52-week low is ₹1,085.00.
What is the market cap of 3B Blackbio Dx?
3B Blackbio Dx's market capitalisation is ₹1,130 Cr (₹1,130 Cr) at the 22 Oct 2026 close, ranking 1394th among the NSE companies Pivot tracks.
What is the ROE and ROCE of 3B Blackbio Dx?
Return on equity was 18.1% in FY26 and return on capital employed was 22.6% in FY26 (consolidated figures).
Is 3B Blackbio Dx a debt-free company?
3B Blackbio Dx is close to debt-free: its debt-to-equity ratio was 0.01 in FY26.
What were 3B Blackbio Dx's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), 3B Blackbio Dx reported revenue of ₹35 Cr, +57.5% year on year, and net profit of ₹10 Cr, +21.9% year on year.
What is the shareholding pattern of 3B Blackbio Dx?
As of 30 Jun 2026: promoters 40.95%, foreign institutions 2.50%, domestic institutions 2.15%, non-institutions 54.40%.
Who are 3B Blackbio Dx's competitors?
The listed Diversified companies closest to 3B Blackbio Dx by market cap are BOMDYEING, Sika Interplant Systems, Grand Oak Canyons Distillery, Kothari Industrial Corporation, Fedders Holding and Safe Enterprise.
Is 3B Blackbio Dx a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out 3B Blackbio Dx's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on 3BBLACKBIO against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Diversified stocks · companies starting with 0-9 · all NSE stocks · this page as text